tirzepatide bone loss GLP-1 Weight-Loss Drugs May Be Thinning Bone: Doctors Are Starting to Have This Conversation with Patients Tirzepatide, a dual GLP-1 and

3 studies referred to GSH but did not give data, 5 studies were conference abstracts we were unable to gain access to this data, despite three attempts at email correspondence with the authors

Journal of Aging and Health 35(9 Suppl):40S-50S

1 INDICATIONS AND USAGE INDICATIONS & USAGE SECTION ZEPBOUND is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition

Fat loss continues at an accelerated rate